The Bristol Institute for Transfusion Sciences (BITS) was established in 1996 under the directorship of Professor David Anstee, with the aim of bringing together research and teaching at the IBGRL, the Bristol Blood Centre and the University of Bristol. 



BITS is a major part of NHSBT Research activity, contributing to all three of the programmes of research:

Better and Safer use of Blood, Stem Cells, Tissues and Organs

Development of Cellular and Tissue Therapies

Immunohaematology and Immunogenetics of Transfusion and Transplantation.


BITS and the Department of Cellular and Molecular Medicine, University of Bristol offer a taught MSc course in Transfusion and Transplantation Sciences.

Research Products

A range of monoclonal antibodies have been developed as a result the R&D programme. These antibodies are available as IBGRL Research Products for sale to other laboratories for research use.

Clinical Biotechnology Centre and the support of immunotherapy trials

The CBC is the first publicly-funded MHRA accredited facility for the manufacture of recombinant proteins and gene therapy investigational medicinal products for clinical trials. 



This page was last updated on 10-Feb-17.